Filing Details
- Accession Number:
- 0001543077-16-000006
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-01-08 10:30:30
- Reporting Period:
- 2015-12-14
- Filing Date:
- 2016-01-08
- Accepted Time:
- 2016-01-08 10:30:30
- Original Submission Date:
- 2015-12-17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1105533 | Argos Therapeutics Inc | ARGS | Pharmaceutical Preparations (2834) | 562110007 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1543077 | D Jeffrey Abbey | Argos Therapeutics, Inc. 4233 Technology Drive Durham NC 27704 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-12-14 | 5,000 | $2.50 | 11,500 | No | 4 | P | Indirect | By IRA |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By IRA |
Footnotes
- Corrects a typographical error in the aggregate number of shares reported for this entry on the reporting person's Form 4 filed on December 17, 2015. The correct aggregate number of shares indirectly held as of such date was as reported above.